Unraveling MASH: Implications for Clinical Practice
A new review in Nature Reviews Gastroenterology & Hepatology clarifies the complex interplay of metabolism, inflammation, and fibrosis in metabolic dysfunction-associated steatohepatitis (MASH). This understanding translates to practical guidance for risk stratification and patient management in primary care settings.
ECPR Rewarming: A Case for Prolonged Resuscitation?
Hypothermia can be protective, even in the face of cardiac arrest and severe coagulopathy. This case challenges the premature termination of resuscitation efforts in severely hypothermic patients undergoing extracorporeal cardiopulmonary resuscitation (ECPR).
Do Condition-Specific Growth Charts Improve Care in Alagille Syndrome?
Growth charts tailored for Alagille Syndrome (ALGS) could refine the assessment of malnutrition in these children, but questions remain about their broad applicability. Clinicians should view these new charts cautiously, considering the limitations of the underlying data and the potential for misinterpretation.
SGLT2 Inhibitors: Promise and Peril in Prader-Willi Syndrome?
SGLT2 inhibitors show potential for managing glycemic control in Prader-Willi Syndrome, but clinicians must be vigilant about the risk of renal complications. This necessitates careful patient selection and close monitoring of kidney function throughout treatment.
Atrial Fibrillation and Cardio-Kidney-Metabolic Risk: A Systemic Challenge
A new analysis highlights the complex interplay of cardio-kidney-metabolic (CKM) risk factors in patients with atrial fibrillation, underscoring the need for integrated care models. The study points to significant policy and reimbursement challenges in establishing multidisciplinary CKM clinics.
